Table 1 Clinical and body composition data.

From: CT-based assessment of sarcopenia for differentiating wild-type from mutant-type gastrointestinal stromal tumor

 

wt-GIST (n = 52)

mu-GIST (n = 122)

P

Age (medium, min–max) (year)

55.0 (28.0–79.0)

54.0 (22.0–84.0)

0.782

Gender (male, %)

30 (57.7)

63 (51.6)

0.464

NLR (medium, min–max)

2.98 (1.15–32.67)

2.55 (0.87–27.00)

0.045*

BMI (mean ± SD)

21.90 ± 2.92

22.45 ± 3.04

0.272

VFA (medium, min–max)

155.75 (10.96–309.91)

81.87 (5.37–247.39)

 < 0.001**

VFI (medium, min–max)

57.38 (3.89–123.76)

31.55 (2.02–89.78)

 < 0.001**

MFI (medium, min–max)

49.57 (0.17–69.33)

2.74 (0.52–10.19)

 < 0.001**

SFI (medium, min–max)

114.94 (8.70–209.14)

46.42 (1.36–129.03)

 < 0.001**

VFI: SFI ratio (medium, min–max)

0.50 (0.16–1.44)

0.68 (0.17–1.85)

0.008**

SMI

41.02 (28.53–57.51)

43.28 (25.32–113.26)

0.022*

Obesity (n, %)

12, 23.1

37, 30.3

0.33

Sarcopenia (n, %)

39, 75.0

59, 48.4

0.001

Visceral obesity (n, %)

40, 76.9

45, 36.9

< 0.001**

  1. NLR Neutrophil to lymphocyte ratio, SD standard deviation, BMI body mass index, VFA Visceral fat area, VFI Visceral fat index, MFI Muscle fat index, SFI Subcutaneous fat index, SMI Skeleton muscle index, Min minimum, Max maximum. *P < 0.05; **P < 0.01.
Back to article page